Insomnia News and Research

Latest Insomnia News and Research

New data from studies evaluating diagnostic tools, therapies for infectious diseases released at ECCMID 2016

New data from ten late-breaking abstracts is released at ECCMID 2016 – the annual meeting of the European Society of Clinical Microbiology and Infectious Disease.

12 Apr 2016

Janssen announces CHMP positive opinion for use of paliperidone palmitate 3-monthly injection for schizophrenia treatment

Janssen UK announced today that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the use of paliperidone palmitate 3-monthly injection for the maintenance treatment of schizophrenia in the European Union.

4 Apr 2016

Social microvolunteering app could support Alzheimer's caregivers

Every day, more than 15 million unpaid caregivers provide care to people with Alzheimer's disease, with little outside support and often at the risk of their own health.

25 Mar 2016

World sleep day tackles poor sleep due to nocturia

Today is World Sleep Day, an annual global event that aims to improve sleep health worldwide. World Sleep Day is organized by the World Association of Sleep Medicine (WASM) to spread awareness of important sleep-related issues and the burden insomnia places on society through a series of special events. This year it is focussing on sleep loss resulting from the need to urinate during the night.

18 Mar 2016

New study reports association between nightmares and suicidal behaviors

A new study is the first to report that the relationship between nightmares and suicidal behaviors is partially mediated by a multi-step pathway via defeat, entrapment and hopelessness.

17 Mar 2016

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Inc. today announced Valeant Pharmaceuticals International, Inc. will commercialize Mysimba (naltrexone HCl / bupropion HCl prolonged release) in Central and Eastern Europe.

15 Mar 2016

Antidepressant paroxetine suppresses inflammation in people with HIV-related cognitive impairment

In a small, placebo-controlled clinical trial, Johns Hopkins physicians report that the antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in people with HIV-associated cognitive impairment. The researchers say they believe this is the first time that a SSRI (selective serotonin reuptake inhibitor) has been shown to improve key measures of cognition in people with HIV in a controlled study.

26 Feb 2016

Insomnia and nightmares may increase depression risk

A new study of firefighters suggests that insomnia and nightmares may increase the risk of depression by impairing the ability to access and leverage emotion regulation strategies effectively.

18 Feb 2016

Caltech researchers identify gene that causes severe insomnia when overactivated

Caltech biologists have performed the first large-scale screening in a vertebrate animal for genes that regulate sleep, and have identified a gene that when overactivated causes severe insomnia. Expression of the gene, neuromedin U (Nmu), also seems to serve as nature's stimulant--fish lacking the gene take longer to wake up in the morning and are less active during the day.

18 Feb 2016

Neural gene promotes growth and spread of metastatic breast cancer

When breast cancer becomes advanced and spreads to other organs, patient survival is drastically reduced, prompting the need to explore the genes that may cause tumor cells to metastasize.

15 Feb 2016

Genetic variants associated with preference to mornings or nights

23andMe, Inc., the leading personal genetics company, today announced the results of a genome-wide association study (GWAS) identifying genetic variants associated with being a morning person.

3 Feb 2016

Anticholinergic medications may not be best option for dementia patients in rehab facility

During rehabilitation following an acute hospital stay, medications that block neurotransmitters may be overprescribed to older patients suffering from delirium superimposed on dementia, according to health researchers.

29 Jan 2016

Reclaim Your Sleep survey: 46% of female patients waiting over five years to be diagnosed with sleep apnoea

46% of female patients with sleep apnoea are suffering with sleep problems for over five years before being correctly diagnosed with the condition.

From ResMed Corp 27 Jan 2016

Migraines heat up as women near menopause

Migraine headaches heat up as women approach menopause, according to a new study from researchers at the University of Cincinnati, Montefiore Headache Center, Albert Einstein College of Medicine and Vedanta Research.

21 Jan 2016

AASM officially launches new telemedicine system to increase patient access to sleep medicine

Today the American Academy of Sleep Medicine officially launched AASM Sleep, a new state-of-the-art telemedicine platform that will dramatically increase patient access to the expertise of board-certified sleep medicine physicians and accredited sleep centers.

20 Jan 2016

Online intervention tool helps rural veteran women suffering from postpartum depression

A University of Iowa researcher is working with the Veterans Administration on a pilot program to help female veterans suffering from postpartum depression.

13 Jan 2016

Alexza receives notification letter regarding noncompliance with NASDAQ listing rule

Alexza Pharmaceuticals, Inc. announced today that on December 17, 2015, the Company received a letter from the Nasdaq Staff indicating that the Company had not regained compliance with the $35 million market capitalization requirement for continued listing on The Nasdaq Capital Market by the end of the previously granted compliance period, which expired on December 16, 2015.

23 Dec 2015

Bern study sheds light on the brain mechanism of arousal

Scientists from Bern have discovered a mechanism which is responsible for the rapid arousal from sleep and anesthesia in the brain. The results of their study suggest new strategies for the medical treatment of sleep disorders and recovery of consciousness in vegetative states.

22 Dec 2015

Alexza reports interim results from AZ-002 Phase 2a study in epilepsy patients

Alexza Pharmaceuticals, Inc. today announced interim results of its Phase 2a study of AZ-002 (Staccato alprazolam) in epilepsy patients. AZ-002 produced a dose-related decrease in mean Standardized Photosensivity Range (SPR), the primary endpoint in the study.

21 Dec 2015

New guidelines may help reduce medication use among seniors

We're not getting any younger. According to the Administration for Community Living, by 2060, there will be about 98 million older persons in the United States — more than twice their number in 2013.

11 Dec 2015

Insomnia News and Research

Latest Insomnia News and Research

New data from studies evaluating diagnostic tools, therapies for infectious diseases released at ECCMID 2016

Janssen announces CHMP positive opinion for use of paliperidone palmitate 3-monthly injection for schizophrenia treatment

Social microvolunteering app could support Alzheimer's caregivers

World sleep day tackles poor sleep due to nocturia

New study reports association between nightmares and suicidal behaviors

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Antidepressant paroxetine suppresses inflammation in people with HIV-related cognitive impairment

Insomnia and nightmares may increase depression risk

Caltech researchers identify gene that causes severe insomnia when overactivated

Neural gene promotes growth and spread of metastatic breast cancer

Genetic variants associated with preference to mornings or nights

Anticholinergic medications may not be best option for dementia patients in rehab facility

Reclaim Your Sleep survey: 46% of female patients waiting over five years to be diagnosed with sleep apnoea

Migraines heat up as women near menopause

AASM officially launches new telemedicine system to increase patient access to sleep medicine

Online intervention tool helps rural veteran women suffering from postpartum depression

Alexza receives notification letter regarding noncompliance with NASDAQ listing rule

Bern study sheds light on the brain mechanism of arousal

Alexza reports interim results from AZ-002 Phase 2a study in epilepsy patients

New guidelines may help reduce medication use among seniors

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Insomnia News and Research

Latest Insomnia News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in